Select Page

PRESS REleASE
SHILPA MEDICARE

Nilotinib

12-05-2023
Greetings from Shilpa Medicare Ltd, India!

We are pleased to inform that Shilpa Medicare has accomplished another feat in the treatment of leukaemia by successfully developing “NILOTINIB 50MG, 150MG & 200 MG CAPSULES”

 

Shilpa press release Nilotibib

Learn more about Shilpa Medicare at our company page on Pharmoaffer